Teleflex Incorporated (TFX) Given Consensus Recommendation of “Hold” by Brokerages
Teleflex Incorporated (NYSE:TFX) has been assigned an average rating of “Hold” from the twelve analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $275.63.
TFX has been the topic of several recent research reports. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $261.00 price objective on the stock in a research report on Tuesday, September 12th. Barclays reaffirmed an “overweight” rating and set a $253.00 price objective (up previously from $230.00) on shares of Teleflex in a research report on Tuesday, September 12th. Jefferies Group reaffirmed a “buy” rating and set a $253.00 price objective (up previously from $230.00) on shares of Teleflex in a research report on Wednesday, August 9th. Deutsche Bank reaffirmed a “buy” rating and set a $251.00 price objective (up previously from $238.00) on shares of Teleflex in a research report on Monday, September 18th. Finally, Stephens reissued a “buy” rating and issued a $270.00 price target (up previously from $230.00) on shares of Teleflex in a research report on Monday, September 25th.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $265.32, for a total value of $53,064.00. Following the sale, the director now owns 8,080 shares in the company, valued at $2,143,785.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Benson Smith sold 2,000 shares of the firm’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $258.10, for a total transaction of $516,200.00. Following the completion of the sale, the chief executive officer now owns 76,634 shares in the company, valued at approximately $19,779,235.40. The disclosure for this sale can be found here. In the last three months, insiders sold 2,600 shares of company stock worth $665,076. Insiders own 2.39% of the company’s stock.
Teleflex (NYSE TFX) opened at $250.10 on Thursday. The firm has a market cap of $11,396.56, a P/E ratio of 31.27, a P/E/G ratio of 2.16 and a beta of 1.09. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex has a 52-week low of $151.22 and a 52-week high of $271.23.
Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. The firm had revenue of $534.70 million for the quarter, compared to analyst estimates of $522.94 million. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The company’s revenue for the quarter was up 17.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.80 earnings per share. equities analysts expect that Teleflex will post 8.35 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Wednesday, November 15th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Tuesday, November 14th. Teleflex’s dividend payout ratio is 24.82%.
WARNING: “Teleflex Incorporated (TFX) Given Consensus Recommendation of “Hold” by Brokerages” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/12/07/teleflex-incorporated-tfx-given-consensus-recommendation-of-hold-by-brokerages.html.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.